Pharmacy Times· Pharmacy
How Stanford Pharmacists Help Close Heart Failure Therapy Gaps
Cody Parsons, APh, PharmD, BCCCP, says protected pharmacist access lets patients with heart failure be seen more often than typical clinic visits allow.
Medical news · Saturday, November 7, 2026
Today in medicine.
Stories from the rxbrief desk, the FDA, the CDC, MedPage Today, Pharmacy Times, and U.S. Pharmacist, updated through the day. Sign in to rank them by your specialty and save the ones you want to read later.
Pharmacy Times· Pharmacy
GLP-1s and Obesity Care: Cardiorenal Outcomes, Prescribing Considerations, and Access Barriers
The evidence for GLP-1 receptor agonists keeps growing, while access for low-income patients keeps narrowing.
Pharmacy Times· Pharmacy
GLP-1 Receptor Agonists and Cancer: Considerations for Specialty Pharmacists
Specialty pharmacists can help patients with cancer weigh the benefits and risks of GLP-1 receptor agonists as use expands and new evidence emerges.
Pharmacy Times· Pharmacy
Who Should Track Gene Therapy Outcomes Long Term? ASTCT Panel Debates Shared Responsibility
If gene therapies are expected to deliver decades of benefit, long-term evidence collection must be coordinated, useful to patients, and financially sustainable.
Pharmacy Times· Pharmacy
Understanding Kratom: Pharmacology, Safety, and Regulation
As kratom questions increase, many pharmacists and other health care professionals may remain unfamiliar it and the potential risks.
Pharmacy Times· Pharmacy
Beyond the Beauty Buzz: Pharmacy Meets Aesthetics
Pharmacists can work alongside dermatologists, nurses, and other health care professionals to help answer skin care–related questions and help patients understand trial outcomes.
Pharmacy Times· Pharmacy
Automated Stem Cell Editing Could Expand Gene Therapy Manufacturing, ASTCT Expert Says
Matthew Porteus, MD, PhD, highlighted preclinical advances in automated stem cell gene editing that could improve manufacturing scalability while supporting the development of next-generation genetic medicines.
Pharmacy Times· Pharmacy
Oncology Pharmacists Say Real-World Factors, Not Trial Data Alone, Guide ICI Choice in NSCLC
Payer requirements, prescriber habits, and operational realities ultimately determine which ICI patients receive.
Pharmacy Times· Pharmacy
Amivantamab Becomes First FDA-Approved Therapy in 10 Years for Pretreated Recurrent or Metastatic HNSCC
Accelerated approval for patients who progressed on platinum and immunotherapy brings a new mechanism—and a familiar toxicity profile.
Pharmacy Times· Pharmacy
FDA Grants Priority Review to Zanubrutinib Plus Rituximab for Previously Untreated MCL
If approved, the combination would be the first chemotherapy-free, Bruton tyrosine kinase inhibitor–based regimen for adults with newly diagnosed mantle cell lymphoma (MCL).
Pharmacy Times· Pharmacy
Gestational Diabetes: New Data on Treatment, Long-Term Risk
Early metformin may curb insulin starts in gestational diabetes, while a separate analysis ties a history of the condition to advanced CKM syndrome.
Pharmacy Times· Pharmacy
Gene Therapy Requires More Than an Infusion: ASTCT Experts Detail Hidden Barriers to Care
Manufacturing delays, financial barriers, and complex care coordination can limit access to gene therapy, emphasizing the need for patient-centered programs and long-term follow-up.